OOIR: Observatory of International Research

Papers

(The TQCC of Hematology-Oncology Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)

Article	Citations
Epidemiology of Melanoma	54
Screening for Colorectal Cancer	47
Molecular Pathogenesis of Mantle Cell Lymphoma	46
Biology of Melanoma	43
Diagnosis and Staging of Bladder Cancer	40
Factor XI Deficiency	39
The Epidemiology of Bladder Cancer	29
Lip and Oral Cavity Squamous Cell Carcinoma	26
Epidemiology of Follicular Lymphoma	23
Nasopharyngeal Carcinoma and Its Association with Epstein-Barr Virus	22
Blastoid Mantle Cell Lymphoma	21
Colorectal Cancer in Younger Adults	21
Overview of Myeloproliferative Neoplasms	21
Disorders of Fibrinogen and Fibrinolysis	20
Von Willebrand Disease	19
Hereditary Colorectal Cancer	18
Current Role and Emerging Evidence for Bruton Tyrosine Kinase Inhibitors in the Treatment of Mantle Cell Lymphoma	17
Epidemiology of the Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms	16
The Epidemiology of Central Nervous System Tumors	16
Genetics of Myeloproliferative Neoplasms	14
Current Therapy and Emerging Intravesical Agents to Treat Non–Muscle Invasive Bladder Cancer	14
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes	14
The Role of Megakaryocytes in Myelofibrosis	14
Rare Coagulation Factor Deficiencies (Factors VII, X, V, and II)	13
Acquired von Willebrand Syndrome	13

Gene Therapy for Hemoglobinopathies	13
The Microenvironment in Myeloproliferative Neoplasms	13
Developing Precision Medicine for Bladder Cancer	13
Acquired Hemophilia A	13
Pancreatic Adenocarcinoma	12
Updates on the Diagnosis and Management of Cold Autoimmune Hemolytic Anemia	11
Primary Central Nervous System Lymphomas	11
Structural Racism and Impact on Sickle Cell Disease	11
Cancer of the Paranasal Sinuses	11
Cellular Therapy and Cytokine Treatments for Melanoma	11
Impact of Diet and Exercise on Colorectal Cancer	11
Current Clinical Investigations in Myelofibrosis	11
Systemic Amyloidosis Due to Clonal Plasma Cell Diseases	10
Gene Therapy and Gene Editing for β-Thalassemia	10
Immunotherapy for Head and Neck Cancer	10
Factor XIII Deficiency	10
Central Nervous System Metastases	10
A Curative DNA Code for Hematopoietic Defects	10
Go the Distance	9
The Process of Amyloid Formation due to Monoclonal Immunoglobulins	9
Managing Recurrent Metastatic Head and Neck Cancer	9
Preclinical Models for Bladder Cancer Research	9
Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer	9
Minimal Residual Disease in Mantle Cell Lymphoma	9
Neurocognition and Health-Related Quality of Life Among Patients with Brain Tumors	9
Systemic Amyloidosis due to Low-Grade Lymphoma	8
Neurofibromatoses	8
Thrombotic, Vascular, and Bleeding Complications of the Myeloproliferative Neoplasms	8
Salivary Gland Cancers	8
Hemophilia A (Factor VIII Deficiency)	8
Monoclonal Antibody Therapies in Systemic Light-Chain Amyloidosis	8
Should Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?	8
Management of Rectal Cancer	8
Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms	8
Quality of Life in Sickle Cell Disease	7
Adult Evans' Syndrome	7
Cancer of the Larynx and Hypopharynx	7
Hemophilia B (Factor IX Deficiency)	7
The Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic Leukemia	7
The Clinical Utility of ESR1 Mutations in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer	7
The Clinical Phenotypes of Alpha Thalassemia	7
Stem Cell Mobilization and Autologous Transplant for Immunoglobulin Light-Chain Amyloidosis	7
Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm Biology	6
Update on Radiation Therapy for Central Nervous System Tumors	6
Liver and Gastrointestinal Involvement	6
Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic Leukemia	6
Real World Outcomes of Patients with Bladder Cancer	6
Chimeric Antigen Receptor T-cell Therapy	6
Application of Stem Cell Therapy in Myelofibrosis	6
Cell Cycle Dysregulation in Mantle Cell Lymphoma	6

Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis	6
Biology and Treatment of HER2-Low Breast Cancer	6
Renal Cell Carcinoma of Variant Histology	6
Allogeneic Transplantation and Chimeric Antigen Receptor-Engineered T-Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma	6
Robotic and Endoscopic Approaches to Head and Neck Surgery	6
Imaging Advances for Central Nervous System Tumors	6
Watch and Wait in Mantle Cell Lymphoma	6
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer	5
Hematopoietic Stem Cell Transplantation in Thalassemia	5
The Biological Basis of Histologic Transformation	5
State of Melanoma	5
Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia	5
Nonoperative Management for Rectal Cancer	5
Quality of Life in Myeloproliferative Neoplasms	5
Genetics of Pancreatic Neuroendocrine Tumors	5
Advanced Melanoma	5
Fetal Hemoglobin Regulation in Beta-Thalassemia	5
Is There a Role for Immunotherapy in Central Nervous System Cancers?	5
Disparities and Inequities Among Patients with Central Nervous System Tumor	5
Systemic Amyloidosis Caused by Monoclonal Immunoglobulins	5
Molecular Basis and Genetic Modifiers of Thalassemia	5
Immune Therapy for Chronic Lymphocytic Leukemia	5
Immunotherapy-associated Autoimmune Hemolytic Anemia	5
Gene Therapy for Inborn Errors of Immunity	5
Molecular Biology of Bladder Cancer	5
Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art	5
Treatment of Histologic Transformation	5
Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia	5
Evolution of Gene Therapy, Historical Perspective	5
Liver and Gastrointestinal Involvement	5
Combinatorial Approaches to the Treatment of Advanced Melanoma	5
Emerging Targeted Therapy for Bladder Cancer	4
Cancer of the Oropharynx and the Association with Human Papillomavirus	4
Chronic Pain	4
Pathogenic Mechanisms in Thalassemia I	4
Supportive Care for Patients with Systemic Light Chain Amyloidosis	4
Immune Checkpoint Therapies for Melanoma	4
Role of Ovarian Suppression in Early Premenopausal Breast Cancer	4
Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer	4
Red Cell Antigens and Antibodies	4
Current Therapy for Metastatic Urothelial Carcinoma	4
Disparities in Breast Cancer Outcomes and How to Resolve Them	4
Approach to the Initial Treatment of Older Patients with Mantle Cell Lymphoma	4
Genetic Modifiers of Sickle Cell Disease	4
Systemic Amyloidosis due to Monoclonal Immunoglobulins	4
Breast Cancer and Lifestyle Factors	4
Epigenetic Dysregulation of Myeloproliferative Neoplasms	4
Surgical Management of the Axilla for Breast Cancer	4
Emerging Therapies in β-Thalassemia	4
The Gut Microbiome in Colorectal Cancer	4
The Evolving Landscape of Drug Therapies for Sickle Cell Disease	4
Surgery for Bladder and Upper Tract Urothelial Cancer	4
Accelerated and Blast Phase Myeloproliferative Neoplasms	4
Biology and Treatment of Meningiomas	4
Future Perspectives	4